Treatment of acute non-A, non-B hepatitis with interferon alpha-2b. 1992

N C Tassopoulos, and M Koutelou, and G Papatheodoridis, and H Polychronaki, and T Giannikakis, and M Paraloglou-Ioannides, and A Hatzakis

UI MeSH Term Description Entries
D008297 Male Males
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077190 Interferon alpha-2 Alpha interferon encoded by the human IFNA2 gene. Recombinant forms are used in the treatment of CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; KAPOSI SARCOMA; MELANOMA; and HAIRY CELL LEUKEMIA. IFN-alpha 2,IFN-alpha-2,IFNalpha-2b, Recombinant,Interferon alfa-2a,Interferon alfa-2b,Interferon alpha-2b, Recombinant,Interferon alpha-A,Interferon-alpha 2,Intron A (Interferon),LeIF A,Reaferon,Recombinant Interferon alpha-2a,Recombinant Interferon alpha-2b,Ro 22-8181,Roferon-A,Sch-30500,Viferon,IFNalpha 2b, Recombinant,Interferon alfa 2a,Interferon alfa 2b,Interferon alpha 2,Interferon alpha 2b, Recombinant,Interferon alpha A,Interferon alpha-2a, Recombinant,Recombinant IFNalpha-2b,Recombinant Interferon alpha 2a,Recombinant Interferon alpha 2b,Ro 22 8181,Ro 228181,Roferon A,RoferonA,Sch 30500,Sch30500
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D016898 Interferon-alpha One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways. Interferon Alfa,Interferon, Leukocyte,Interferon, Lymphoblast,alpha-Interferon,IFN-alpha D,IFN-alpha5,Interferon alpha-1,Interferon alpha-17,Interferon alpha-4,Interferon alpha-5,Interferon alpha-7,Interferon alpha-88,Interferon alpha-J,Interferon alpha-T,Interferon alpha4,Interferon alpha5,Interferon, Lymphoblastoid,Interferon, alpha,LeIF I,LeIF J,Leif D,IFN alpha D,IFN alpha5,Interferon alpha,Interferon alpha 1,Interferon alpha 17,Interferon alpha 4,Interferon alpha 5,Interferon alpha 7,Interferon alpha 88,Interferon alpha J,Interferon alpha T,Leukocyte Interferon,Lymphoblast Interferon,Lymphoblastoid Interferon,alpha Interferon

Related Publications

N C Tassopoulos, and M Koutelou, and G Papatheodoridis, and H Polychronaki, and T Giannikakis, and M Paraloglou-Ioannides, and A Hatzakis
March 1990, Deutsche medizinische Wochenschrift (1946),
N C Tassopoulos, and M Koutelou, and G Papatheodoridis, and H Polychronaki, and T Giannikakis, and M Paraloglou-Ioannides, and A Hatzakis
January 1990, Gastroenterologisches Journal : Organ der Gesellschaft fur Gastroenterologie der DDR,
N C Tassopoulos, and M Koutelou, and G Papatheodoridis, and H Polychronaki, and T Giannikakis, and M Paraloglou-Ioannides, and A Hatzakis
November 2002, Der Internist,
N C Tassopoulos, and M Koutelou, and G Papatheodoridis, and H Polychronaki, and T Giannikakis, and M Paraloglou-Ioannides, and A Hatzakis
September 2002, Der Internist,
N C Tassopoulos, and M Koutelou, and G Papatheodoridis, and H Polychronaki, and T Giannikakis, and M Paraloglou-Ioannides, and A Hatzakis
January 1993, Journal of hepatology,
N C Tassopoulos, and M Koutelou, and G Papatheodoridis, and H Polychronaki, and T Giannikakis, and M Paraloglou-Ioannides, and A Hatzakis
January 1990, Journal of hepatology,
N C Tassopoulos, and M Koutelou, and G Papatheodoridis, and H Polychronaki, and T Giannikakis, and M Paraloglou-Ioannides, and A Hatzakis
November 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
N C Tassopoulos, and M Koutelou, and G Papatheodoridis, and H Polychronaki, and T Giannikakis, and M Paraloglou-Ioannides, and A Hatzakis
July 2004, Journal of gastroenterology and hepatology,
N C Tassopoulos, and M Koutelou, and G Papatheodoridis, and H Polychronaki, and T Giannikakis, and M Paraloglou-Ioannides, and A Hatzakis
March 2003, Gastroenterologie clinique et biologique,
N C Tassopoulos, and M Koutelou, and G Papatheodoridis, and H Polychronaki, and T Giannikakis, and M Paraloglou-Ioannides, and A Hatzakis
February 1991, Liver,
Copied contents to your clipboard!